Department of Infection and Immunology, Clinical Research Center, Nagoya Medical Center, 4-1-1 Sannomaru, Nakaku, Nagoya 4600001, Japan.
J Clin Microbiol. 2011 Mar;49(3):1017-24. doi: 10.1128/JCM.02149-10. Epub 2011 Jan 19.
The major routes of hepatitis B virus (HBV) infection in Japan has been mother-to-child transmission (MTCT) and blood transfusion. However, HBV cases transmitted through sexual contact are increasing, especially among HIV-1-seropositive patients. To understand the molecular epidemiology of HBV in HBV/HIV-1 coinfection, we analyzed HBV genotypes and HIV-1 subtypes in HBV/HIV-1-coinfected patients at Nagoya Medical Center from 2003 to 2007. Among 394 HIV-1-infected Japanese men having sex with men (MSM) who were newly diagnosed during the study period, 31 (7.9%) tested positive for the hepatitis B virus surface antigen. HBV sequence analyses were successful in 26 cases, with 21 (80.7%) and 5 (19.3%) cases determined as genotypes A and C, respectively. Our finding that HBV genotype A was dominant in HIV-1-seropositive patients alerts clinicians to an alternative outbreak of HBV genotype A in the HIV-1-infected MSM population and a shift in HBV genotype from C to A in Japan. The narrow genetic diversity in genotype A cases suggests that genotype A has been recently introduced into the MSM population and that sexual contacts among MSM were more active than speculated from HIV-1 tree analyses. In addition, we found a lamivudine resistance mutation in one naïve case, suggesting a risk of drug-resistant HBV transmission. As genotype A infection has a higher risk than infection with other genotypes for individuals to become HBV carriers, prevention programs are urgently needed for the target population.
乙型肝炎病毒 (HBV) 在日本的主要感染途径是母婴传播 (MTCT) 和输血。然而,通过性接触传播的 HBV 病例正在增加,尤其是在 HIV-1 血清阳性患者中。为了了解 HBV/HIV-1 合并感染中 HBV 的分子流行病学,我们分析了 2003 年至 2007 年期间名古屋医疗中心 HBV/HIV-1 合并感染患者的 HBV 基因型和 HIV-1 亚型。在研究期间新诊断的 394 名与男性发生性关系的 HIV-1 感染日本男性 (MSM) 中,有 31 名 (7.9%) 乙型肝炎病毒表面抗原检测呈阳性。HBV 序列分析在 26 例中获得成功,其中 21 例 (80.7%) 和 5 例 (19.3%) 分别确定为基因型 A 和 C。我们发现 HIV-1 血清阳性患者中 HBV 基因型 A 占优势,这提醒临床医生注意 HIV-1 感染 MSM 人群中 HBV 基因型 A 的另一次暴发,以及日本 HBV 基因型从 C 向 A 的转变。基因型 A 病例的遗传多样性狭窄表明,基因型 A 最近已被引入 MSM 人群,并且 MSM 之间的性接触比从 HIV-1 树分析推测的更为活跃。此外,我们在一例初治病例中发现了拉米夫定耐药突变,提示存在耐药 HBV 传播的风险。由于基因型 A 感染比其他基因型感染对个体成为 HBV 携带者的风险更高,因此迫切需要针对目标人群的预防计划。